| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Cell. & Molec. Physiology, Penn State College Medicine, United States
* To whom correspondence should be addressed. E-mail: clang{at}psu.edu.
Prolonged sepsis and exposure to an inflammatory milieu decreases muscle protein synthesis and reduces muscle mass. As a result of its ability to integrate diverse signals, including hormones and nutrients, the mammalian target of rapamycin (mTOR) is a dominant regulator in the translational control of protein synthesis. Under post-absorptive conditions, sepsis decreases mTOR kinase activity in muscle, as evidenced by reduced phosphorylation of both eukaryotic initiation factor (eIF)-4E binding protein (BP)-1 and ribosomal S6 kinase (S6K)-1. These sepsis-induced changes along with the redistribution of eIF4E from the active eIF4E∙eIF4G complex to the inactive eIF4E∙4EBP1 complex are preventable by neutralization of tumor necrosis factor (TNF)-
, but not by antagonizing glucocorticoid action. While the ability of mTOR to respond to insulin-like growth factor (IGF)-I is not disrupted by sepsis, the ability of leucine to increase 4E-BP1 and S6K1 phosphorylation is greatly attenuated. This 'leucine resistance' results from a cooperative interaction between both TNF and glucocorticoids. Finally, although septic animals are not IGF-I-resistant, the anabolic actions of IGF-I are nonetheless reduced because of the development of growth hormone resistance which decreases both circulating and muscle IGF-I. Herein we highlight recent advances in the mTOR signaling network, and emphasize their connection to the atrophic response observed in skeletal muscle during sepsis. Although many unanswered questions remain, understanding the cellular basis of the sepsis-induced decrease in translational activity will contribute to the rational development of therapeutic interventions and thereby minimize the debilitating affects of the atrophic response that impairs patient recovery.
This article has been cited by other articles:
|
|
 |
|
  M. Miyazaki and K. A. Esser REDD2 is enriched in skeletal muscle and inhibits mTOR signaling in response to leucine and stretch Am J Physiol Cell Physiol, March 1, 2009; 296(3): C583 - C592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Crossland, D. Constantin-Teodosiu, S. M. Gardiner, D. Constantin, and P. L. Greenhaff A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscle J. Physiol., November 15, 2008; 586(22): 5589 - 5600. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Pruznak, A. A. Kazi, R. A. Frost, T. C. Vary, and C. H. Lang Activation of AMP-Activated Protein Kinase by 5-Aminoimidazole-4-Carboxamide-1-{beta}-D-Ribonucleoside Prevents Leucine-Stimulated Protein Synthesis in Rat Skeletal Muscle J. Nutr., October 1, 2008; 138(10): 1887 - 1894. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. J. Smith, S. H. Lecker, and P.-O. Hasselgren Calpain activity and muscle wasting in sepsis Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E762 - E771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. M. Pruznak, L. Hong-Brown, R. Lantry, P. She, R. A. Frost, T. C. Vary, and C. H. Lang Skeletal and cardiac myopathy in HIV-1 transgenic rats Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E964 - E973. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A. Frost and C. H. Lang Regulation of muscle growth by pathogen-associated molecules J Anim Sci, April 1, 2008; 86(14_suppl): E84 - E93. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
